World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03090035
Date of registration: 27/02/2017
Prospective Registration: No
Primary sponsor: Sheikh Zayed Medical College
Public title: Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment
Scientific title: Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses in Chronic Hepatitis C Treatment
Date of first enrolment: January 1, 2014
Target sample size: 98
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03090035
Study type:  Interventional
Study design:  Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 3
Countries of recruitment
Pakistan
Contacts
Name:     Muhammad ZM Babar, FCPS
Address: 
Telephone:
Email:
Affiliation:  Sheikh Zayed Medical College/Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- patients with diagnosis of chronic hepatitis C genotype 2 or 3

Exclusion Criteria:

- Patients with hepatitis genotype I and IV



Age minimum: 20 Years
Age maximum: 80 Years
Gender: All
Health Condition(s) or Problem(s) studied
Hepatitis C Relapse
Hepatitis C
Intervention(s)
Drug: Ribavirin
Drug: Pegylated Interferon a2
Primary Outcome(s)
Treatment Success rate [Time Frame: after 24 weeks of treatment]
Secondary Outcome(s)
Relapse Rate [Time Frame: After 48 weeks of treament]
Sustained Virological Response [Time Frame: After 48 weeks of treament]
Secondary ID(s)
sheikhZMC
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history